Y-Mabs Therapeutics Inc

NASDAQ:YMAB 4:00:00 PM EDT

8.61

+0.02 (+0.23%)

4:22:13 PM EDT: $8.59 -0.02 (-0.23%)

Market Cap (Intraday)	392.12M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$20.77 Million
Adjusted EPS	-$0.22

See more estimates

10-Day MA	$8.58
50-Day MA	$7.02
200-Day MA	$6.10

See more pivots

Y-Mabs Therapeutics Inc Stock, NASDAQ:YMAB

202 Carnegie Center, Suite 301, Princeton, New Jersey 08540

United States of America

Phone: +1.646.885.8505

Number of Employees: 107

http://www.ymabs.com

Description

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in Princeton, NJ.